Compare Adobe Systems Inc (ADBE) vs Novo Nordisk A/S (NVO) Price & Performance

Adobe Systems Inc

Novo Nordisk A/S

Price performance

Price movement over the last 24 hours

Key statistics

Adobe Systems Inc vs Novo Nordisk A/S — how do they compare? Adobe Systems Inc trades at $220.6 (market cap $88.06B), while Novo Nordisk A/S trades at $48.88 (market cap $220.20B). The key difference: Novo Nordisk A/S is far larger — about 2.5× Adobe Systems Inc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Adobe Systems Inc pays none. Which is the better fit depends on your goals.

	ADBE	NVO
Market Cap	$88.06B	$220.20B
Volume	5,187,646	—
Sector	Technology	Health
52-Week High	$382.24	$71.70
52-Week Low	$193.41	$35.29
Enterprise Value	$89.50B	$239.16B
Dividend Yield	—	3.63%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Adobe Systems Inc

Adobe Inc. (ADBE) trades at $220.94, up 1.32% today, with strong fundamentals including 29.99% net income margin and consistent earnings beats. Technical analysis shows a bullish overall signal despite mixed moving averages, with key support at $218 and resistance at $228. Recent news highlights institutional buying activity and AI-driven growth in its BPC segment, though some analysts express caution about AI competition.

The outlook remains positive with a consensus price target of $246.75 (11.7% upside), supported by robust cash flow and double-digit revenue growth. Key risks include AI disruption fears and CEO transition uncertainty, but the stock's current valuation at 12.67 P/E offers relative value in the software sector.

Novo Nordisk A/S

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ADBE

Adobe trades at a low 11.6x P/E amid AI fears, offering room for EPS growth via share buybacks.Seeking Alpha · 4 hours agoBullish Samsung earnings drop sparks sell-off in AI hardware, boosts megacap tech stocksCNBC · 1 day agoNeutral Adobe shares drop 35% in 2026 amid doubts over AI strategy and pricing model.Market Watch · 1 day agoBearish View details →

NVO

Novo Nordisk shares fell after Deutsche Bank reported a slowdown in prescriptions for its oral weight-loss drug Wegovy.Proactive Investors · 12 hours agoBearish UBS favors European pharma over AI, citing resilience and growth from weight-loss drugs.Proactive Investors · 15 hours agoBullish Weight loss drug market to hit $130-150B by 2035, with ETFs like THNR targeting this growth.ETF Trends · 1 day agoBullish View details →

About Adobe Systems Inc

Adobe Inc. develops, markets, and supports computer software products and technologies. The Company's products allow users to express and use information across all print and electronic media. Adobe offers a line of application software products, type products, and content for creating, distributing, and managing information.

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.